Vyant Bio Inc Watch

from 10-Q ~10 pages Forbearance and Sixth Amendment to Amended and Restated Loan and Security Agreement

from 8-K 12 pages Forbearance Agreement and Modification No. 4 to Loan and Security Agreement

from 8-K 11 pages Forbearance and Fifth Amendment to Amended and Restated Loan and Security Agreement

from 8-K 32 pages Credit Agreement Dated as of September 18, 2018 Among Cancer Genetics, Inc. as Borrower and Novellusdx, Ltd. as Lender

from 425 32 pages Credit Agreement Dated as of September 18, 2018 Among Cancer Genetics, Inc. as Borrower and Novellusdx, Ltd. as Lender

from 8-K 9 pages Waiver and Modification No. 3 to Loan and Security Agreement

from 8-K 8 pages Waiver and Third Amendment to Amended and Restated Loan and Security Agreement

from 8-K 20 pages Joinder and Modification No. 2 to Loan and Security Agreement

from 8-K 36 pages Joinder and Second Amendment to Amended and Restated Loan and Security Agreement

from 10-K 19 pages This Warrant ("Warrant") to Purchase Shares in the Capital of Cancer Genetics, Inc., a Delaware Corporation (The “Company”) Is Issued on the Issue Date Pursuant to the Terms of That Certain Loan and Security Agreement Between the Company and Partners for Growth IV, L.P. (“Pfg” and Such Agreement, the “Loan Agreement”). This Warrant and the Underlying Shares Are Sold in a Private Transaction, Without Registration Under the Securities Act of 1933, as Amended, and Regulations Promulgated Thereunder (The "Securities Act") or the Securities Laws of Any State, and May Be Offered or Sold Only if Registered Under the Securities Act and Such Laws or if an Exemption From Registration Under the Securities Act and Such Laws Is Available. Company: Cancer Genetics, Inc., a Delaware Corporation (NASDAQ: CGIX Warrant Stock: Common Stock Number of Shares: Up to 265,957 Shares, Subject to Adjustment Exchange Price: $2.82 Per Share, Subject to Adjustment Issue Date: March 22, 2017 Expiration Date: March 22, 2024 the Term "Holder" Shall Initially Refer to Partners for Growth IV, L.P., a Delaware Limited Partnership, Which Is the Initial Holder of This Warrant and Shall Further Refer to Any Subsequent Permitted Holder of This Warrant From Time to Time

from 10-K 38 pages Loan and Security Agreement

from 10-K 44 pages Amended and Restated Loan and Security Agreement

from 10-Q 35 pages Loan and Security Agreement

from 8-K 3 pages Wells Fargo Bank, National Association Revolving Line of Credit Note

from 8-K 12 pages Credit Terms

from S-1/A 1 page March 19, 2013 Nnjca Capital, LLC 100 First Street – Suite 301 Hackensack, New Jersey 07601 Attention: Dr. Andrew Pecora Re: Amended and Restated Credit Agreement With Cancer Genetics, Inc. Dear Dr. Pecora

from S-1/A 1 page March 19, 2013 Dam Holdings, LLC 1418 N. Lakeshore Drive, Suite 29 Chicago, Il 60610 Attention: Matthew Bluhm Re: Credit Agreement With Cancer Genetics, Inc., as Amended Dear Matthew: Very Truly Yours, Cancer Genetics, Inc. By: /S/ Panna L. Sharma Panna L. Sharma President and CEO Agreed to and Accepted By: Dam Holdings, LLC By: /S/ Matthew Bluhm Name: Matthew Bluhm Title: President

from S-1/A 1 page February 13, 2013 Dam Holdings, LLC 1418 N. Lakeshore Drive, Suite 29 Chicago, Il 60610 Attention: Matthew Bluhm Re: Credit Agreement With Cancer Genetics, Inc., as Amended Dear Matthew: Very Truly Yours, /S/ Panna L. Sharma Panna L. Sharma President and CEO Agreed to and Accepted By: Dam Holdings, LLC By: /S/ Matthew Bluhm Name: Matthew Bluhm Title: President

from S-1/A 1 page February 13, 2013 Nnjca Capital, LLC 100 First Street - Suite 301 Hackensack, New Jersey 07601 Attention: Dr. Andrew Pecora Re: Amended and Restated Credit Agreement With Cancer Genetics, Inc. Dear Dr. Pecora: Very Truly Yours, /S/ Panna L. Sharma Panna L. Sharma President and CEO Agreed to and Accepted By: Nnjca Capital, LLC By: /S/ Andrew Pecora Name: Andrew Pecora Title: Manager

from S-1/A 1 page February 13, 2013 John Pappajohn 666 Walnut Street, Ste 2116 Des Moines, Ia 50309 Re: Amended and Restated Credit Agreement With Cancer Genetics, Inc. Dear John: Very Truly Yours, /S/ Panna L. Sharma Panna L. Sharma President and CEO Agreed to and Accepted By: /S/ John Pappajohn John Pappajohn